Term
|
Definition
-induces labor
-SE antiduiretic, uterine spasm, arrhythmia,
-SE (fetus) CNS damage/sz
-IV |
|
|
Term
|
Definition
-mixed V1 and V2 vasopressin receptor antagonist
-tx SIADH
-IV |
|
|
Term
|
Definition
-V2 vasopressin receptor antagonist
-tx SIADH and HF too
-PO |
|
|
Term
|
Definition
-tx SIADH
-tetracycline antibiotic
-SE diabetes insipidus |
|
|
Term
|
Definition
-tx SIADH
-reduces aquaporin-2 expression
-SE diabetes insipidus
-rare |
|
|
Term
|
Definition
-tx diabetes insipidus
-stimulates V2
-IV,SQ,IN,PO,SL |
|
|
Term
|
Definition
-recombinant HGH
-tx confirmed GH def
-SE intracranial HTN, neoplasam, pancreatitis
-IM, SQ |
|
|
Term
|
Definition
| tx GH def-recombinant IGF-1 -SE hypoglycemia, sz, slipped upper femoral epiphysis, intracranial HTN -SQ |
|
|
Term
|
Definition
-tx GH excess
-SRL (more potent and longer t1/2 than somatostatin)
-SE-glucose regulation changes, arrhythmia, bradycardia, gallstones
-LAR-IM/IV (monthly), SQ |
|
|
Term
|
Definition
-investigational SRL
-inc specificity |
|
|
Term
|
Definition
-tx excess GH
-DA agonist
-PO |
|
|
Term
|
Definition
-tx excess GH
-GH receptor antagonist
-SE inc LFTs
-long half life
-SQ
-expensive |
|
|
Term
|
Definition
-tx high PRL
-DA agonist
-SE arrythmia, MI, HF, pulmonary fibrosis
-PO |
|
|
